Overview
- 16 FDA inspections are on record.
- 7 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-06-19.
At a glance
Inspections
16
Form 483s
7
EIRs
2
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 15 Jun 2026 – 19 Jun 2026 | Animal Drugs & Feeds | Clean | |
| 23 Feb 2026 – 27 Feb 2026 | Human Drugs | 483 | View 483 → |
| 15 Jan 2020 – 24 Jan 2020 | Human Drugs | 483 | View 483 → |
| 25 Jun 2019 – 11 Jul 2019 | Human Drugs | 483 | View 483 → |
| 21 Aug 2018 – 3 Oct 2018 | Human Drugs | 483 | View 483 → |
| 11 Apr 2017 – 26 Apr 2017 | Human Drugs | 483 | View 483 → |
| 27 May 2015 – 1 Jun 2015 | Human Drugs | Clean | |
| 10 Mar 2014 – 21 Mar 2014 | Human Drugs | 483 | On file |
| 12 Jan 2012 | Not recorded | Clean | |
| 11 May 2011 | Not recorded | Clean | |
| 24 Jun 2009 | Not recorded | Clean | |
| 24 Oct 2008 | Not recorded | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
11 Jul 2019
21 CFR 211.166(a)(2)
Stability sample storage conditions described
Cited by Camerson E Moore
Investigators
FDA investigators tied to this site in the record.
Stephen D Brown5 insp.
Camerson E Moore2 insp.
Demario L Walls1 insp.
Timothy H Vo1 insp.
Shatina R Alridge1 insp.
Jason R Caballero1 insp.
Ademola O Daramola1 insp.
Andrea A Branche1 insp.
Kenitra D Hewitt1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 8x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.180(e)(1) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 314.80(b) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.111 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.166(a)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.188(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.46(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 2x |
Full site report
Get the verbatim findings behind Brio Pharmaceuticals Inc's 7 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat